vs
德康医疗（DXCM）与KeyCorp（KEY）财务数据对比。点击上方公司名可切换其他公司
KeyCorp的季度营收约是德康医疗的1.6倍（$2.0B vs $1.3B），KeyCorp净利率更高（25.4% vs 21.2%，领先4.2%），KeyCorp同比增速更快（131.8% vs 21.6%），过去两年KeyCorp的营收复合增速更高（14.4% vs 12.0%）
德康医疗是美国跨国医疗保健企业，专注于研发、生产及销售糖尿病管理领域的连续血糖监测（CGM）系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥，生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
Key是日本知名视觉小说工作室，1998年7月21日作为发行商Visual Arts旗下品牌成立，总部位于大阪市北区。工作室主打剧情向作品，擅长创作情感饱满、情节跌宕的戏剧类内容，旗下多款作品深受全球ACG爱好者喜爱。
DXCM vs KEY — 直观对比
营收规模更大
KEY
是对方的1.6倍
$1.3B
营收增速更快
KEY
高出110.2%
21.6%
净利率更高
KEY
高出4.2%
21.2%
两年增速更快
KEY
近两年复合增速
12.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $2.0B |
| 净利润 | $267.3M | $510.0M |
| 毛利率 | 62.9% | — |
| 营业利润率 | 25.6% | 32.3% |
| 净利率 | 21.2% | 25.4% |
| 营收同比 | 21.6% | 131.8% |
| 净利润同比 | 153.6% | 309.0% |
| 每股收益（稀释后） | $0.67 | $0.43 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DXCMKEY
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $2.0B | ||
| Q3 25 | $1.2B | $1.9B | ||
| Q2 25 | $1.2B | $1.8B | ||
| Q1 25 | $1.0B | $1.8B | ||
| Q4 24 | $1.1B | $865.0M | ||
| Q3 24 | $994.2M | $695.0M | ||
| Q2 24 | $1.0B | $1.5B |
净利润DXCMKEY
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $510.0M | ||
| Q3 25 | $283.8M | $489.0M | ||
| Q2 25 | $179.8M | $425.0M | ||
| Q1 25 | $105.4M | $405.0M | ||
| Q4 24 | $151.7M | $-244.0M | ||
| Q3 24 | $134.6M | $-410.0M | ||
| Q2 24 | $143.5M | $274.0M |
毛利率DXCMKEY
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
营业利润率DXCMKEY
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 32.3% | ||
| Q3 25 | 20.1% | 31.8% | ||
| Q2 25 | 18.4% | 29.3% | ||
| Q1 25 | 12.9% | 29.0% | ||
| Q4 24 | 17.0% | -92.6% | ||
| Q3 24 | 15.3% | -72.8% | ||
| Q2 24 | 15.7% | 22.0% |
净利率DXCMKEY
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 25.4% | ||
| Q3 25 | 23.5% | 25.8% | ||
| Q2 25 | 15.5% | 23.1% | ||
| Q1 25 | 10.2% | 22.8% | ||
| Q4 24 | 13.6% | -54.7% | ||
| Q3 24 | 13.5% | -59.0% | ||
| Q2 24 | 14.3% | 18.0% |
每股收益（稀释后）DXCMKEY
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $0.43 | ||
| Q3 25 | $0.70 | $0.41 | ||
| Q2 25 | $0.45 | $0.35 | ||
| Q1 25 | $0.27 | $0.33 | ||
| Q4 24 | $0.37 | $-0.30 | ||
| Q3 24 | $0.34 | $-0.47 | ||
| Q2 24 | $0.35 | $0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $917.7M | $10.2B |
| 总债务越低越好 | — | $9.9B |
| 股东权益账面价值 | $2.7B | $20.4B |
| 总资产 | $6.3B | $184.4B |
| 负债/权益比越低杠杆越低 | — | 0.49× |
8季度趋势，按日历期对齐
现金及短期投资DXCMKEY
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $10.2B | ||
| Q3 25 | $1.8B | $13.3B | ||
| Q2 25 | $1.2B | $11.6B | ||
| Q1 25 | $904.9M | $15.3B | ||
| Q4 24 | $606.1M | $17.5B | ||
| Q3 24 | $621.2M | $22.8B | ||
| Q2 24 | $939.2M | $15.5B |
总债务DXCMKEY
| Q1 26 | — | — | ||
| Q4 25 | — | $9.9B | ||
| Q3 25 | — | $10.9B | ||
| Q2 25 | — | $12.1B | ||
| Q1 25 | — | $12.4B | ||
| Q4 24 | — | $12.1B | ||
| Q3 24 | — | $15.7B | ||
| Q2 24 | — | $16.9B |
股东权益DXCMKEY
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $20.4B | ||
| Q3 25 | $2.7B | $20.1B | ||
| Q2 25 | $2.6B | $19.5B | ||
| Q1 25 | $2.3B | $19.0B | ||
| Q4 24 | $2.1B | $18.2B | ||
| Q3 24 | $2.0B | $16.9B | ||
| Q2 24 | $2.4B | $14.8B |
总资产DXCMKEY
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $184.4B | ||
| Q3 25 | $7.5B | $187.4B | ||
| Q2 25 | $7.3B | $185.5B | ||
| Q1 25 | $6.8B | $188.7B | ||
| Q4 24 | $6.5B | $187.2B | ||
| Q3 24 | $6.4B | $189.8B | ||
| Q2 24 | $6.8B | $187.4B |
负债/权益比DXCMKEY
| Q1 26 | — | — | ||
| Q4 25 | — | 0.49× | ||
| Q3 25 | — | 0.54× | ||
| Q2 25 | — | 0.62× | ||
| Q1 25 | — | 0.65× | ||
| Q4 24 | — | 0.67× | ||
| Q3 24 | — | 0.93× | ||
| Q2 24 | — | 1.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $2.2B |
| 自由现金流经营现金流 - 资本支出 | — | $2.1B |
| 自由现金流率自由现金流/营收 | — | 104.8% |
| 资本支出强度资本支出/营收 | — | 5.3% |
| 现金转化率经营现金流/净利润 | — | 4.33× |
| 过去12个月自由现金流最近4个季度 | — | $3.5B |
8季度趋势，按日历期对齐
经营现金流DXCMKEY
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $2.2B | ||
| Q3 25 | $659.9M | $396.0M | ||
| Q2 25 | $303.0M | $1.2B | ||
| Q1 25 | $183.8M | $-140.0M | ||
| Q4 24 | $301.4M | $664.0M | ||
| Q3 24 | $199.5M | $-1.2B | ||
| Q2 24 | $279.4M | $-217.0M |
自由现金流DXCMKEY
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $2.1B | ||
| Q3 25 | $579.4M | $367.0M | ||
| Q2 25 | $208.9M | $1.2B | ||
| Q1 25 | $96.8M | $-150.0M | ||
| Q4 24 | $176.8M | $599.0M | ||
| Q3 24 | $88.3M | $-1.2B | ||
| Q2 24 | $213.3M | $-230.0M |
自由现金流率DXCMKEY
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 104.8% | ||
| Q3 25 | 47.9% | 19.4% | ||
| Q2 25 | 18.1% | 65.8% | ||
| Q1 25 | 9.3% | -8.5% | ||
| Q4 24 | 15.9% | 69.2% | ||
| Q3 24 | 8.9% | -175.8% | ||
| Q2 24 | 21.2% | -15.1% |
资本支出强度DXCMKEY
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 5.3% | ||
| Q3 25 | 6.7% | 1.5% | ||
| Q2 25 | 8.1% | 1.3% | ||
| Q1 25 | 8.4% | 0.6% | ||
| Q4 24 | 11.2% | 7.5% | ||
| Q3 24 | 11.2% | 2.4% | ||
| Q2 24 | 6.6% | 0.9% |
现金转化率DXCMKEY
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 4.33× | ||
| Q3 25 | 2.33× | 0.81× | ||
| Q2 25 | 1.69× | 2.90× | ||
| Q1 25 | 1.74× | -0.35× | ||
| Q4 24 | 1.99× | — | ||
| Q3 24 | 1.48× | — | ||
| Q2 24 | 1.95× | -0.79× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
